Healthcare & Life Sciences
Topas Therapeutics
Germanytopas-therapeutics.com
Topas Therapeutics is a Healthcare & Life Sciences startup based in Germany, most recent round Series B, 4 tracked investors.
Activeseries-b
series-b
Stage
2017
Founded
4
Investors
About Topas Therapeutics
Topas Therapeutics is a startup founded in 2017 based in Germany. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.
Topas Therapeutics develops antigen-specific nanoparticle therapies designed to induce immune tolerance by targeting liver endothelial cells, aiming to treat autoimmune and immune-mediated diseases, with clinical programs including Phase 2 trials in celiac disease.
Explore Topas Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.